Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 4 1

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Cardiotoxicity 1

Interventions

Metformin 16 Cyclophosphamide 16 Drug Therapy 14 Dexamethasone 14 Cisplatin 13 Cytarabine 11 Gemcitabine 10 Radiotherapy 9 Oxaliplatin 9 Carboplatin 9 Vincristine 8 Paclitaxel 8 Idarubicin 8 Etoposide 8 Docetaxel 8 ulipristal acetate 7 icotinib 7 Sodium Chloride 7 Methotrexate 7 Fluorouracil 7 Dexmedetomidine 7 entecavir 6 Thalidomide 6 Surgical Procedures, Operative 6 Sorafenib 6 Pemetrexed 6 Leuprolide 6 Granulocyte Colony-Stimulating Factor 6 Epirubicin 6 Doxorubicin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × Carvedilol × Clear all

NCT04939883 2024-06-28

CardioTox

Hospital Sirio-Libanes

Phase 4 Unknown

Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡